Second, we analyzed the KRAS expression level with the characteristics of tumor patients, tumor stage, tumor microenvironment, and immune cell infiltration of 33 kinds of tumors; finally, we investigated the molecular mechanisms by GO and KEGG analysis. This evidence concerns the gene KRAS and neoplasm.